Scouted: ‘Nature’s Ozempic’? Experts Weigh in on the Budding GLP-1 Supplement Boom
Scouted selects products independently. If you purchase something from our posts, we may earn a small commission. Unless you ...
New Truveta study highlights patterns of discontinuation and reinitiation of GLP-1 RA medications
New research published in JAMA Network Open led by Truveta Research and Ezekiel Emanuel, MD, PhD, Perelman School of Medicine ...
American Association of Individual Investors15h
Why MBX Biosciences, Inc.’s (MBX) Stock Is Down 14.00%
MBX Biosciences, Inc.’s MBX share price has dipped by 14.00%, which has investors questioning if this is right time to buy.
Armed robbery in Revesby23h
GLP-1 Agonist Use Paused, Resumed in Overweight Adults
In this cohort study, most patients with overweight or obesity discontinued glucagon-like peptide-1 receptor agonist (GLP-1 RA ...
Irish Examiner1hOpinion
Weight-loss ‘wonder drugs’ show a darker side as some fall into illness
Wonder drugs’ like Ozempic, hailed by celebrities and some medics as a cure for an ever-mounting list of conditions, most ...
Healio23h
Most adults with overweight or obesity discontinue GLP-1 therapy within 2 years
More than half of adults with overweight or obesity prescribed a GLP-1 discontinue their drug within 1 year, with discontinuation rates higher for those without type 2 diabetes, researchers reported ...
TCTMD17h
Cardiometabolic Trends Dominate First Round of Drugs Chosen for Medicare Price Negotiations
The IRA measure is a good first step, but some are looking even further ahead to GLP-1 price drops to increase access.
Everyday Health20h
The Link Between Your Heart Health and MASH
Learn how managing high blood pressure and high cholesterol keeps your heart health in check and helps prevent liver issues such as MASH.